Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
none considered needed
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Clinical efficacy of IBD drug therapy | Endoscopic, clinical and biochemical response | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Fatigue in patients with coeliac disease - substudy | Fatigue severity and prevalence at diagnosis and after one year of gluten free diet | 1 year |
| Fatigue in IBD | Fatigue severity and prevalence at diagnosis and during follow-up |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All newly diagnosed IBD patients (Crohns and Ulcerative colitis) within Stavanger Univ Hospital catchment area
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| tore grimstad | Contact | tore.bjorn.grimstad@sus.no | ||
| lars aabakken | Contact | larsaa@medisin.uio.no |
| Name | Affiliation | Role |
|---|---|---|
| Tore Grimstad, PhD | Helse Stavanger HF | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| SUS | Recruiting | Stavanger | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37766922 | Derived | Skjellerudsveen BM, Omdal R, Hetta AK, Kvaloy JT, Aabakken L, Skoie IM, Grimstad T. Less, but not gone-gluten-free diet effects on fatigue in celiac disease: a prospective controlled study. Front Med (Lausanne). 2023 Sep 12;10:1242512. doi: 10.3389/fmed.2023.1242512. eCollection 2023. | |
| 28040992 | Derived | Grimstad T, Skoie IM, Doerner J, Isaksen K, Karlsen L, Aabakken L, Omdal R, Putterman C. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease. Scand J Gastroenterol. 2017 Apr;52(4):420-424. doi: 10.1080/00365521.2016.1273382. Epub 2016 Dec 31. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Plasma and mucosal biopsies Fecal sampling
| 5 years |
| IBD and the intestinal microbiome | Microbiome/eukaryome profiles associated with disease activity and treatment response from diagnosis and during follow-up | 5 years |
| 25994356 | Derived | Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A, Karlsen LN, Skoie IM, Goransson L, Harboe E, Aabakken L, Omdal R. Fatigue in Newly Diagnosed Inflammatory Bowel Disease. J Crohns Colitis. 2015 Sep;9(9):725-30. doi: 10.1093/ecco-jcc/jjv091. Epub 2015 May 19. |